Aggrastat is used to treat acute coronary syndrome by reducing platelet aggregation within the coronary arteries. This
improves blood flow to the heart muscle and reduces the risk of serious cardiac complications in patients with unstable
angina or coronary artery disease.
The drug is also used during percutaneous transluminal angioplasty (PTA) to support the success of the procedure and
reduce the likelihood of blood clot formation during and after the procedure.
Aggrastat in uae helps stabilize the heart and improve treatment outcomes when used as part of a comprehensive treatment
plan under close medical supervision.